Njambe Priso, Ghislain Donald
Lissom, Abel
NGU, Loveline N.
Nji, Nadesh N.
Tchadji, Jules Colince
Tchouangueu, Thibau Flaurant
Ambada, Georgia E.
Ngane, Carole Stéphanie Sake
Dafeu, Brigitte Laure
Djukouo, Larissa
Nyebe, Inès
Magagoum, Suzanne
Ngoh, Apeh Alfred
Herve, Ouambo Fotso
Garcia, Rosario
Gutiérrez, Anna
Okoli, Arinze S.
Esimone, Charles O.
Njiokou, Flobert
Park, Chae Gyu
Waffo, Alain Bopda
Nchinda, Godwin W.
Funding for this research was provided by:
EDCTP (TA.2010.40200.016)
TWAS (12059RG/bio/af/ac_G)
Grand Challenges Canada (0121-01)
CIRCB (PTA-2012-2017)
African Korean collaborative grand (NRF-2013KIA3A1A09076155)
Article History
Received: 25 October 2017
Accepted: 26 March 2018
First Online: 4 April 2018
Ethics approval and consent to participate
: All human samples in the AFRODEC Cohort were collected with written informed consent under clinical protocols approved by the Republic of Cameroon National Ethics Committee (protocol number 2014/10/499/CE/CNERSH/SP) the CIRCB institutional review board (protocol number 14-11) and the Cameroon government administrative authorization (authorization number 631-1112). The AFRODEC cohort consists of adult HIV-1 infected participants aged 21 to 65 years who were naïve to antiretroviral therapy.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.